Sequence-specific detection method for reverse transcription, loop-mediated isothermal amplification of HIV-1.

PubWeight™: 1.24‹?› | Rank: Top 10%

🔗 View Article (PMID 19382260)

Published in J Med Virol on June 01, 2009

Authors

Kelly A Curtis1, Donna L Rudolph, S Michele Owen

Author Affiliations

1: Laboratory Branch, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. czv2@cdc.gov

Articles citing this

Point-of-care nucleic acid testing for infectious diseases. Trends Biotechnol (2011) 2.57

A simple, inexpensive device for nucleic acid amplification without electricity-toward instrument-free molecular diagnostics in low-resource settings. PLoS One (2011) 1.50

Isothermal amplification using a chemical heating device for point-of-care detection of HIV-1. PLoS One (2012) 1.43

Challenges for rapid molecular HIV diagnostics. J Infect Dis (2010) 1.06

A low-cost microfluidic chip for rapid genotyping of malaria-transmitting mosquitoes. PLoS One (2012) 1.03

Electricity-free amplification and detection for molecular point-of-care diagnosis of HIV-1. PLoS One (2014) 0.96

Real-Time Detection of HIV-2 by Reverse Transcription-Loop-Mediated Isothermal Amplification. J Clin Microbiol (2014) 0.89

Detection of Acute HIV-1 Infection by RT-LAMP. PLoS One (2015) 0.88

Loop-mediated amplification accelerated by stem primers. Int J Mol Sci (2011) 0.83

Development of Recombinase Polymerase Amplification Assays for Detection of Orientia tsutsugamushi or Rickettsia typhi. PLoS Negl Trop Dis (2015) 0.81

Static self-directed sample dispensing into a series of reaction wells on a microfluidic card for parallel genetic detection of microbial pathogens. Biomed Microdevices (2015) 0.80

A fully integrated paperfluidic molecular diagnostic chip for the extraction, amplification, and detection of nucleic acids from clinical samples. Lab Chip (2016) 0.80

Nucleic acid testing by public health referral laboratories for public health laboratories using the U.S. HIV diagnostic testing algorithm. J Clin Virol (2015) 0.78

A reverse transcription loop-mediated isothermal amplification assay optimized to detect multiple HIV subtypes. PLoS One (2015) 0.78

Miniaturized devices for point of care molecular detection of HIV. Lab Chip (2017) 0.75

Single-use, electricity-free amplification device for detection of HIV-1. J Virol Methods (2016) 0.75

Isothermal assay targeting class 1 integrase gene for environmental surveillance of antibiotic resistance markers. J Environ Manage (2017) 0.75

Articles by these authors

Rapid detection of HIV-1 by reverse-transcription, loop-mediated isothermal amplification (RT-LAMP). J Virol Methods (2008) 2.14

Evaluation of the performance characteristics of 6 rapid HIV antibody tests. Clin Infect Dis (2011) 1.69

Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections. J Clin Virol (2011) 1.66

Performance of an alternative laboratory-based algorithm for HIV diagnosis in a high-risk population. J Clin Virol (2011) 1.52

Activity of alpha- and theta-defensins against primary isolates of HIV-1. J Immunol (2004) 1.50

Isothermal amplification using a chemical heating device for point-of-care detection of HIV-1. PLoS One (2012) 1.43

An isothermal amplification reactor with an integrated isolation membrane for point-of-care detection of infectious diseases. Analyst (2011) 1.25

RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates. AIDS Res Hum Retroviruses (2004) 1.23

Lower-sensitivity and avidity modifications of the vitros anti-HIV 1+2 assay for detection of recent HIV infections and incidence estimation. J Clin Microbiol (2012) 1.18

Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay. J Clin Virol (2011) 1.15

Development and characterization of a bead-based, multiplex assay for estimation of recent HIV type 1 infection. AIDS Res Hum Retroviruses (2011) 1.11

Generation of a consensus sequence from prevalent and incident HIV-1 infections in West Africa to guide AIDS vaccine development. Virology (2002) 1.08

Challenges for rapid molecular HIV diagnostics. J Infect Dis (2010) 1.06

Delayed maturation of antibody avidity but not seroconversion in rhesus macaques infected with simian HIV during oral pre-exposure prophylaxis. J Acquir Immune Defic Syndr (2011) 1.05

Rapid detection of HIV-1 p24 antigen using magnetic immuno-chromatography (MICT). J Virol Methods (2009) 1.01

Performance of a fourth-generation HIV screening assay and an alternative HIV diagnostic testing algorithm. AIDS (2013) 0.98

Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established HIV-1 infection and blood donors. J Clin Virol (2011) 0.92

Comparison of alternative interpretive criteria for the HIV-1 Western blot and results of the Multispot HIV-1/HIV-2 Rapid Test for classifying HIV-1 and HIV-2 infections. J Clin Virol (2011) 0.91

The effect of sample handling on cross sectional HIV incidence testing results. PLoS One (2011) 0.90

A rapid real-time PCR assay for the detection of HIV-1 proviral DNA using double-stranded primer. J Virol Methods (2009) 0.90

Evaluation of a multiplex assay for estimation of HIV-1 incidence. PLoS One (2013) 0.87

Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay. PLoS One (2010) 0.86

Coreceptor utilization of HIV type 1 subtype E viral isolates from Thai men with HIV type 1-infected and uninfected wives. AIDS Res Hum Retroviruses (2002) 0.82

Inter-laboratory assessment of a prototype multiplex kit for determination of recent HIV-1 infection. PLoS One (2013) 0.81

Repeat confirmatory testing for persons with discordant whole blood and oral fluid rapid HIV test results: findings from post marketing surveillance. PLoS One (2008) 0.79

Chemokine receptor gene polymorphisms and risk of human T lymphotropic virus type I infection in Jamaica. J Infect Dis (2002) 0.78

Rapid detection and differentiation of antibodies to HIV-1 and HIV-2 using multivalent antigens and magnetic immunochromatography testing. Clin Vaccine Immunol (2010) 0.75

Longitudinal analysis of HIV-1-specific antibody responses. AIDS Res Hum Retroviruses (2014) 0.75

Comparative evaluation of Aptima HIV-1 Qualitative RNA assay performance using plasma and serum specimens from persons with established HIV-1 infection. J Clin Virol (2011) 0.75